Kagan and Soai win 2026 Chemistry Nobel for autocatalysis discovery

On 5 October 2026, the Nobel Prize in Chemistry was announced in Stockholm, Sweden, to two distinguished chemists: Henri B. Kagan of the Université Paris‑Saclay and Kensō Soai of the Tokyo University of Science. The laureates were jointly awarded for their pioneering discovery of non‑linear effects and autocatalysis in asymmetric organic synthesis, a breakthrough that has reshaped the way chiral molecules are produced in the laboratory and in industry. The announcement came after a year of deliberation by the Royal Swedish Academy of Sciences, which highlighted the profound impact of their work on the development of pharmaceuticals and fine chemicals.

Henri B. Kagan, born in 1930, has long been a leading figure in the field of asymmetric catalysis. During his career he developed a series of chiral ligands and catalytic systems that enable the selective formation of one enantiomer over another. These catalysts have become integral to the manufacture of many drugs, allowing manufacturers to produce active pharmaceutical ingredients (APIs) with higher purity and yield. Kagan’s research has also spurred the creation of new catalytic methodologies that reduce waste and improve sustainability in chemical synthesis, aligning with global efforts to make the chemical industry greener.

Kensō Soai, a Japanese chemist, made his name through the discovery of autocatalytic asymmetric synthesis in the early 1990s. By demonstrating that a chiral product could catalyze its own formation, Soai revealed a fundamental principle of chemical self‑organization. His work showed that small chiral biases could be amplified to produce a single enantiomer, a phenomenon that has implications far beyond drug synthesis, including theories of the origin of biological homochirality. Soai’s research has prompted a surge of studies into autocatalytic systems and has opened new avenues for designing self‑propagating reactions in industrial settings.

The Nobel committee’s citation focuses on two key concepts: non‑linear effects and autocatalysis. Non‑linear effects refer to situations where the relationship between catalyst loading and product enantiomeric excess is not a simple straight line; small changes in conditions can lead to large swings in selectivity. Autocatalysis, as discovered by Soai, is a self‑reinforcing process where the product of a reaction acts as a catalyst for its own formation, leading to exponential amplification of chirality. Together, these phenomena provide chemists with powerful tools to achieve high enantiomeric purity under milder conditions, reducing energy consumption and waste. The implications for industrial chemistry are significant: processes can be made more efficient, safer, and cost‑effective, while also enabling the synthesis of complex molecules that were previously difficult or impossible to produce with the required stereochemical fidelity.

The global chemical community has welcomed the award as a recognition of the long‑term value of fundamental research in asymmetric synthesis. Universities and research institutes worldwide are now investing more heavily in the development of chiral catalysts and autocatalytic systems. Pharmaceutical companies, in particular, are exploring how these advances can streamline the production of APIs, potentially lowering production costs and shortening development timelines for new drugs. The award also underscores the importance of international collaboration, as Kagan’s and Soai’s careers illustrate the cross‑border nature of modern scientific discovery.

For Taiwan, the Nobel Prize has practical implications that extend beyond academic prestige. The island hosts one of the world’s largest integrated semiconductor manufacturing ecosystems and a growing biopharmaceutical sector that relies heavily on efficient chiral synthesis for drug development. The principles of non‑linear catalysis and autocatalysis could enable Taiwanese manufacturers to adopt more selective and sustainable processes, reducing reliance on imported raw materials and cutting production costs. Moreover, the recognition of Japanese and French chemists may encourage further academic and industrial partnerships across the Asia‑Pacific region, fostering technology transfer and joint research initiatives that could strengthen Taiwan’s position in the global supply chain for high‑value chemicals and pharmaceuticals.